SCHEMBL7744103

SCHEMBL7744103

CCOc1cncc(C=CCC(C)N)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.59
CHRNA4 P43681 2/20 0.59
CHRNB4 P30926 1/20 0.59
CHRNA3 P32297 1/20 0.59
CHRNA7 P36544 1/20 0.59
AKT1 P31749 10/20 0.49
HTR2A P28223 3/20 0.44
ROCK2 O75116 4/20 0.42
PIM1 P11309 4/20 0.42
PRKACA P17612 4/20 0.42
ROCK1 Q13464 4/20 0.42
DYRK1A Q13627 4/20 0.42
MAP4K4 O95819 3/20 0.42
CLK2 P49760 3/20 0.42
PRKX P51817 3/20 0.42
PRKG1 Q13976 3/20 0.42
PKN2 Q16513 3/20 0.42
CLK4 Q9HAZ1 3/20 0.42
MKNK2 Q9HBH9 3/20 0.42
STK17A Q9UEE5 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4242133 0.87 CHRNB2 (0.58) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL4242134 0.87 CHRNB2 (0.58) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL3838406 0.85 CHRNB2 (0.53) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL2170794 0.84 CHRNB2 (0.71) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL621422 0.84 CHRNB2 (0.71) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL2168872 0.84 CHRNB2 (0.71) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL2170239 0.84 CHRNB2 (0.71) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL2168879 0.84 CHRNB2 (0.71) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL2169514 0.84 CHRNB2 (0.71) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL621421 0.84 CHRNB2 (0.71) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1011672-A4 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR ELICITING ANALGESIC EFFECTS UNIV VIRGINIA COMMONWEALTH (US) 2001-04-04 EP disclosed
EP-1011672-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR ELICITING ANALGESIC EFFECTS VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-06-28 EP disclosed
EP-0873050-A4 PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF ULCERATIVE COLITIS REYNOLDS TOBACCO CO R (US) 1999-09-22 EP disclosed
WO-1999007369-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR ELICITING ANALGESIC EFFECTS VIRGINIA COMMONWEALTH UNIVERSITY (US) 1999-02-18 WO disclosed
EP-0873050-A1 PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF ULCERATIVE COLITIS R.J. REYNOLDS TOBACCO COMPANY (US) 1998-10-28 EP disclosed
EP-0801646-A4 PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS REYNOLDS TOBACCO CO R (US) 1998-03-25 EP disclosed
EP-0801646-A1 PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS R.J. REYNOLDS TOBACCO COMPANY (US) 1997-10-22 EP disclosed
WO-1996020929-A1 PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS R.J. REYNOLDS TOBACCO COMPANY (US) 1996-07-11 WO disclosed
WO-1996020599-A1 PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF ULCERATIVE COLITIS R.J. REYNOLDS TOBACCO COMPANY (US) 1996-07-11 WO disclosed